Wednesday's community calendarTuesday, July 19, 2011 @ 11:35PMJULY 20 Story Time 2-3 p.m. July 20 and 27, Roundhouse Railroad Museum, 601 W. Harris St. Join Miss Rebecca for stories themed to the season, hands-on art projects and singing. Cost: $4 per child with regular adult admission For information, call 912-651-6823, ext. 3, or go to chsgeorgia.org. “Pack the Park” 7 p.m. July 20, Grayson Stadium, 1401 E. Victory Drive. Interfaith Hospitality of ...
Roche signs agreement to acquire mtm laboratoriesTuesday, July 19, 2011 @ 1:39AMVentana Medical Systems, Inc., a member of the Roche Group, announced today that Roche has signed an agreement under which it will acquire 100 percent of mtm laboratories AG (mtm), a privately-held company based in Heidelberg, Germany.
Competitive Technologies to Sell BiCOM's Medical DevicesFriday, July 15, 2011 @ 10:56AMCompetitive Technologies to Sell BiCOM''s Medical Devices Competitive Technologies, Inc. 15.07.2011 17:39 ------------------------------------------------------------------
DGAP-News: Competitive Technologies to Sell BiCOM´s Medical Devices (deutsch)Friday, July 15, 2011 @ 10:54AMCompetitive Technologies to Sell BiCOM´s Medical Devices Competitive Technologies, Inc. 15.07.2011 17:39 FAIRFIELD, Conn., 2011-07-15 17:39 CEST (GLOBE NEWSWIRE) …
Sanofi Reports Positive Top-Line Results from First Phase 3 Study of Alemtuzumab (Lemtrada™ (*)) in Multiple SclerosisMonday, July 11, 2011 @ 12:57AMPARIS--(BUSINESS WIRE)--Genzyme announced today positive top-line results from CARE-MS I.
Amgen files sBLA for XGEVA with FDA to treat castrate-resistant prostate cancerTuesday, June 28, 2011 @ 1:35AMAmgen today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) to expand the indication for XGEVA (denosumab) to treat men with castrate-resistant prostate cancer to reduce the risk of developing bone metastases.
Press ReleaseTuesday, June 14, 2011 @ 8:03AMInternational Stem Cell Corporation (OTCBB:ISCOE) announces the discovery of a novel, patent-pending technology to produce unlimited numbers of liver cells (hepatocytes) that are free of contamination with potentially dangerous undifferentiated cells.
BDCC hands out prize money to area businessesThursday, June 9, 2011 @ 3:36PMBRATTLEBORO -- More than $67,000 in prize money was handed out to new and expanding businesses in Windham County at the annual Brattleboro Development Credit Corporation business plan competition.
Elbit Imaging Announces Availability of its Annual Report on Form 20-F Through its Website Pursuant to Nasdaq Listing ...Thursday, June 9, 2011 @ 3:38AMElbit Imaging Ltd. , today announced that its annual report on Form 20-F for the year ended December 31, 2010, as filed with the U.S. Securities and Exchange Commission on June 6, 2011 is available through its website at: http://www.elbitimaging.com under: "Investor Relations - Financial Reports - 2010 - 20F/Form 2010."